TDC
59
-8
DFS
54
-3
FITB
53
-5
PCAR
46
-3
CLX
64
2
WBA
45
-3
SCHW
36
-4
DVA
75
-2
HOG
53
-3
AAPL
46
-3
WU
10
-2
EQIX
69
-5
CB
61
3
GOOG
71
2
PEP
51
3
XRAY
31
-6
NOC
50
3
CHK
27
-2
CMA
50
-3
ABBV
44
-2
TDC
59
-8
DFS
54
-3
FITB
53
-5
PCAR
46
-3
CLX
64
2
WBA
45
-3
SCHW
36
-4
DVA
75
-2
HOG
53
-3
AAPL
46
-3
WU
10
-2
EQIX
69
-5
CB
61
3
GOOG
71
2
PEP
51
3
XRAY
31
-6
NOC
50
3
CHK
27
-2
CMA
50
-3
ABBV
44
-2
Financhill
Back

EyePoint Pharmaceuticals Vs. Editas Medicine Industry Stock Comparison

Sell
40

EYPT
EyePoint Pharmaceuticals

Last Price:
8.23
Seasonality Move:
-9.25%
Sell
34

EDIT
Editas Medicine

Last Price:
3.24
Seasonality Move:
20.06%
Sell
40
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.01. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.28. The Score for EDIT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 42.06 Sell
Chaikin Money Flow: 232993 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.06 - 8.9) Sell
Bollinger Bands (100): (8.03 - 10.53) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 32.94 Sell
Chaikin Money Flow: -745563 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.47 - 3.83) Sell
Bollinger Bands (100): (3.88 - 5.52) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.22 Sell
20-day SMA: 8.42 Sell
50-day SMA: 8.66 Sell
200-day SMA: 15.98 Sell
8-day EMA: 8.2 Sell
20-day EMA: 8.4 Sell
50-day EMA: 8.83 Sell
200-day EMA: 12.03 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.5 Sell
20-day SMA: 3.64 Sell
50-day SMA: 4.1 Sell
200-day SMA: 6.3 Sell
8-day EMA: 3.49 Sell
20-day EMA: 3.65 Sell
50-day EMA: 4.05 Sell
200-day EMA: 5.84 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):